Pharma conference to focus on AI based drug development

Korea |  News | 0 Comment | 04 Oct, 2018

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and the Korea Health Industry Development Institute (KHIDI) would be holding “AI Pharma Korea Conference&rdqu...Read more

Kangstem, Orgenesis ink deal to develop cell therapies for atopic dermatitis

Korea |  News | 0 Comment | 02 Oct, 2018

Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that Kangstem Biotech, a biotechnology company specializing in developing cell therapies ...Read more

GC Pharma receives approval for seasonal influenza vaccine

Korea |  News | 0 Comment | 01 Oct, 2018

GC Pharma (formerly known as Green Cross) has announced that it has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) expanding the indication for GCFLU Quadri...Read more

Skin acne treatment equipment AFit gets US FDA approval

Korea |  News | 0 Comment | 26 Sep, 2018

Korea's Hironic, a medical device manufacturer specializing in skin care, announced on the 15th that Afit, an acne treatment equipment that combines 1450nm laser and RF, has obtained FDA an...Read more

Celltrion signs agreement for atherosclerosis drugs development

Korea |  News | 0 Comment | 20 Sep, 2018

Celltrion, a leading biopharmaceutical company headquartered in Incheon, Korea has signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and ...Read more

Inovio Pharma, Geneone Lifesciences announce Ph1 study of Hep C vaccine

Korea |  News | 0 Comment | 13 Sep, 2018

Inovio Pharmaceuticals and Korea's GeneOne Life Science have announced that they have dosed the first patient in a Phase 1 study designed to evaluate a preventive vaccine against hepatitis ...Read more

Korea approves Opdivo-Yervoy for renal cell carcinoma treatment

Korea |  News | 0 Comment | 10 Sep, 2018

The Korean government has approved Ono Pharma Korea and Bristol-Myers Squibb Korea to sell Opdivo (nivolumab)-Yervoy (ipilimumab) combination therapy as the first-line immunotherapy to trea...Read more

KAIST researchers develop device for flexible drug delivery

Korea |  News | 0 Comment | 03 Sep, 2018

A team of researchers at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea has developed a flexible drug delivery device. The team has fabricated a device consi...Read more

Medytox files BLA of botulinum toxin

Korea |  News | 1 Comment | 30 Aug, 2018

Medytox has said that it has filed a biologics license application with the Taiwan Food and Drug Administration for the sale of its botulinum toxin Neuronox. Neuronox, also known as Medito...Read more

Viromed acquires US-based DNA Production Facility

Korea |  News | 0 Comment | 27 Aug, 2018

Korea-based ViroMed  announced the acquisition of a plasmid DNA production facility in San Diego, California from Vical Incorporated. With ViroMed's first Phase III clinical ...Read more

Novartis appoints new CEO for controversial Korean unit

Korea |  News | 0 Comment | 23 Aug, 2018

Singapore- Novartis has appointed the former chief of its Asia Pacific operations, Joshi Venugopal, as interim CEO of its Korea business replacing another interim CEO, Klaus Ribbe, who plan...Read more

Cellect, Cell2in teams to improve stem cell quality

Korea |  News | 0 Comment | 21 Aug, 2018

Singapore - Cellect Biotechnology, a developer of a novel stem cell production technology, announced that it has signed a collaboration agreement with Cell2in, a South Korean comp...Read more

Cellect receives patent for Stem Cell Selection Technology in Korea

Korea |  News | 0 Comment | 20 Aug, 2018

Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, has received a Notice of Allowance from the Korean Intellectual Property Office for its patent titled, "D...Read more

Health Canada approves Daewoong’s BTX

Korea |  News | 0 Comment | 20 Aug, 2018

Daewoong Pharmaceutical has received sales approval for Nabota, its botulinum toxin (BTX) product to treat forehead wrinkles, from Health Canada. Nabota became the first product initially ...Read more

Macrogen receives CAP accreditation in two clinical labs in Korea

Korea |  News | 0 Comment | 14 Aug, 2018

Macrogen, Inc., a precision medicine biotechnology company has announced that its two next generation sequencing (NGS) clinical laboratories, located in its Seoul headquarters and Bundang P...Read more

J&J launches Robotics & Digital surgery QuickFire Challenge in Seoul

Korea |  News | 0 Comment | 13 Aug, 2018

Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation today announced the launch of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in colla...Read more

Macrogen to Use Blockchain for Genomic Big Data

Korea |  News | 0 Comment | 08 Aug, 2018

South-Korean biotech enterprise Macrogen, the country’s leading gene sequencing service provider, is developing a genomic big data blockchain-based platform together with a local tech...Read more

Myanmar, S. Korea to collaborate in health sector

Korea |  News | 0 Comment | 06 Aug, 2018

Myanmar's Yangon University of Pharmacy and South Korea's Chung-Ang University have reached a memorandum of understanding (MoU) to cooperate in the health sector. Under the MoU signed in Y...Read more